Skip to main content

Table 2 Pattern of recurrence for different adjuvant therapies

From: The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa–IVa lower thoracic oesophageal squamous cell carcinoma

Distribution S (n = 32) S + CT (n = 23) S + RT (n = 26) S + CRT (n = 46) Total (n = 127)
Recurrence 27 (84.4%) 20 (87.0%) 15 (57.7%)* 26 (56.5%)* 88 (69.3%)
Lymph node 22 (68.8%) 19 (82.6%) 13 (50.0%) 19 (41.3%)* 73 (57.5%)
Anastomosis 2 (6.3%) 2 (8.7%) 1 (3.8%) 2 (4.3%) 7 (5.5%)
Haematology 8 (25.0%) 5 (21.7%) 7 (26.9%) 12 (26.1%) 32 (25.2%)
Mixed 5 (15.6%) 5 (21.7%) # 5 (19.2%) # 7 (15.2%) 22 (17.3%)
No recurrence 5 (15.6%) 3 (13.0%) 11 (42.3%)* 20 (43.5%)* 39 (30.7%)
  1. #Recurrence was found in the lymph nodes, anastomosis, and haematologically at the same time. *The recurrence rate had a statistically significant difference compared to S (p < 0.05)